Skip to main content
Log in

Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls

  • Esophageal, Gastric, And Duodenal Disorders
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Most cases of esophageal stricture are associated with acid/peptic reflux esophagitis. While patients with strictures commonly have disordered lower esophageal sphincters and poor clearance and neutralization mechanisms, it is not known whether they also have abnormal gastric secretion. This study examined fasting, basal, and stimulated acid and pepsin secretion. With an endoscopic diagnosis of esophagitis, patients with stricture (<12.5 mm) were matched for age, sex, concurrent gastrointestinal disease (duodenal ulcer,N=9), Zollinger-Ellison syndrome (N=6), and postgastric surgery state (N=5), as well as the absence of ulcer disease (non-DU,N=37). Fasting, basal, and pentagastrin-stimulated acid and pepsin secretion were measured. Overall, the 57 stricture patients had the same acid and pepsin secretion as their matched controls with esophagitis; the same was true for each of the subgroups (ZES, DU, non-DU, and postsurgical). Stricture patients weighed less and had a lower body mass index (P<0.01). Patients with esophageal peptic stricture have the same acid and pepsin output as control patients matched for sex, age, background gastrointestinal disease, and the presence of esophagitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marks RD, Richter JE: Peptic strictures of the esophagus. Am J Gastroenterol 88:1160–1173, 1993

    PubMed  Google Scholar 

  2. McCord GS, Clouse RE: Pill-induced esophageal strictures: Clinical features and risk factors for development. Am J Med 88:512–518, 1990

    PubMed  Google Scholar 

  3. Bozymski EM, Isaacs KL: Miscellaneous diseases of the esophagus.In: Textbook of Gastroenterology, 2nd ed. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein (eds). Philadelphia, JB Lippincott, 1995, pp 1283–1302

    Google Scholar 

  4. Terblanche J, Khan D, Bornman P: Long-term injection sclerotherapy treatment for esophageal varices: A 10-year prospective evaluation. Ann Surg 210:725–731, 1989

    PubMed  Google Scholar 

  5. Fine J-D: Management of acquired bullous skin diseases. N Engl J Med 333:1475–1484, 1995

    PubMed  Google Scholar 

  6. Boyce GA, Boyce HW Jr: Esophagus: Anatomy and structural anomalies.In: Textbook of Gastroenterology, 2nd ed. T Yamada, DH Alpers, C Owyang, DW Powell, FE Silverstein (eds). Philadelphia, JB Lippincott, 1995, pp 1156–1174

    Google Scholar 

  7. Palmer ED: The hiatus hernia-esophagitis-esophageal stricture complex: Twenty-year prospective study. Am J Med 44:566–579, 1968

    PubMed  Google Scholar 

  8. Barham CP, Gotley DC, Mills A, Alderson D: Oesophageal acid clearance in patients with severe reflux oesophagitis. Br J Surg 82:333–337, 1995

    PubMed  Google Scholar 

  9. Hopwood D: Oesophageal defense mechanisms. Digestion 56:5–8, 1995

    PubMed  Google Scholar 

  10. Brown CM, Rees WDW: Factors protecting the oesophagus against acid-mediated injury. Aliment Pharmacol Ther 9:251–262, 1995

    PubMed  Google Scholar 

  11. Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149–1158, 1991

    PubMed  Google Scholar 

  12. Hirschowitz BI: Acid and pepsin secretion in patients with esophagitis refractory to treatment with H2 antagonists. Scand J Gastroenterol 27:449–452, 1992

    PubMed  Google Scholar 

  13. Hirschowitz BI: Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls. Dig Dis Sci 41:1384–1391, 1996

    PubMed  Google Scholar 

  14. Spechler SJ, Sperber H, Doos WG, et al: The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures. Dig Dis Sci 28:769–774, 1983

    PubMed  Google Scholar 

  15. Hirschowitz BI: Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 86:843–851, 1984

    PubMed  Google Scholar 

  16. Kirkpatrick PM Jr, Hirschowitz BI: Duodenal ulcer with unexplained marked basal gastric acid hypersecretion. Gastroenterology 79:4–10, 1980

    PubMed  Google Scholar 

  17. Hirschowitz BI, Groarke J: Vagal effects on acid and pepsin secretion and serum gastrin in duodenal ulcer and controls. Dig Dis Sci 38:1874–1884, 1993

    PubMed  Google Scholar 

  18. Haggitt RC: Barrett's esophagus: Definition and histology.In: Accomplishments in Oncology. Premalignant Lesions of the Esophagus and Colon. BI Hirschowitz (ed). Philadelphia, JB Lippincott, 1989, pp 19–28

    Google Scholar 

  19. McClave SA, Boyce HW, Gottfried MR: Early diagnosis of columnar-lined esophagus: A new endoscopic diagnostic criterion. Gastrointest Endosc 33:413–416, 1987

    PubMed  Google Scholar 

  20. Marks RD, Richter JE, Rizzo J, Koehler RE, Spenney JG, Mills TP, Champion G: Omeprazole versus H2-receptor antagonists in treating patients with peptic stricture and esophagitis. Gastroenterology 106:907–915, 1994

    PubMed  Google Scholar 

  21. Smith PM, Kerr GD, Cockel R, Ross BA, Bate CM, Brown P, Dronfield W, Green JRB, Hislop WS, Theodossi A, et al: A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Gastroenterology 107:1312–1318, 1994

    PubMed  Google Scholar 

  22. Hirschowitz BI, Keeling D, Lewin M, Okabe S, Parsons M, Sewing K, Wallmark B, Sachs G: Pharmacological aspects of acid secretion. Dig Dis Sci 40:3S-23S, 1995

    PubMed  Google Scholar 

  23. Korsten MA, Rosman AS, Fishbein S, et al: Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 90:701–706, 1991

    PubMed  Google Scholar 

  24. Helm JF, Dodds WJ, Pelc LR, et al: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310:284–288, 1984

    PubMed  Google Scholar 

  25. Helm JF, Dodds WJ, Hogan WJ: Salivary responses to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 93:1393–1397, 1987

    PubMed  Google Scholar 

  26. Helm JF, Dodds WJ, Riedel DR, et al: Determinants of esophageal acid clearance in normal subjects. Gastroenterology 85:607–612, 1983

    PubMed  Google Scholar 

  27. Mittal RK, Rochester DF, McCallum RW: Sphincteric action of the diaphragm during a relaxed LES in humans. Am J Physiol 256:6139–6144, 1989

    Google Scholar 

  28. Larrain A, Csendes A, Uribe P, et al: Manometric evaluation after posterior gastropexy for treatment of strictures of the esophagus secondary to reflux. Surg Gynecol Obstet 136:564–566, 1973

    PubMed  Google Scholar 

  29. Berstad A, Weberg R, Froyshov I, et al: Relationship of hiatus hernia to reflux esophagitis. A prospective study of incidence using endoscopy. Scand J Gastroenterol 21:55, 1986

    PubMed  Google Scholar 

  30. Hiatt GA: The roles of esophagoscopy vs radiography in diagnosing benign peptic esophageal strictures. Gastrointest Endosc 23:194–195, 1977

    PubMed  Google Scholar 

  31. Mittal RK, Holloway R, Dent J: Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology 109:1547–1554, 1995

    PubMed  Google Scholar 

  32. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J: Transient lower esophageal sphincter relaxation. Gastroenterology 109:601–610, 1995

    PubMed  Google Scholar 

  33. Baldi F, Ferrarini F, Longanesi A, et al: Oesophageal function before, during, and after healing of erosive oesophagitis. Gut 29:157–160, 1988

    PubMed  Google Scholar 

  34. Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A: Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91:897–904, 1986

    PubMed  Google Scholar 

  35. Singh P, Adamopoulos A, Taylor RH, Colin-Jones DG: Oesophageal motor function before and after healing of oesophagitis. Gut 33:1590–1596, 1992

    PubMed  Google Scholar 

  36. Hollwarth ME, Smith J, Kvietys PR, Granger DN: Esophageal blood flow in the cat. Normal distribution and effects of acid perfusion. Gastroenterology 90:622–627, 1986

    PubMed  Google Scholar 

  37. Lanas A, Sousa FL, Esteva F, Ortego J, Blas J, Sainz R: Aspirin Aspirin (ASA) renders the esophageal mucosa more permeable to acid and pepsin in rabbits. Gastroenterology 104:A129, 1993

    Google Scholar 

  38. Bonavina L, DeMeester TR, McChesney L, et al: Pill-induced esophagitis. Ann Surg 206:173–183, 1987

    PubMed  Google Scholar 

  39. Marks R, Richter JE, Lanas A, Hirschowitz BI: High prevalence of aspirin use among patients with peptic esophageal strictures. Am J Gastroenterol 87:43A, 1992

    Google Scholar 

  40. Hirschowitz BI: Pepsin in the pathogenesis of peptic ulceration.In: Mechanisms of Peptic Ulcer Healing. F Halter, A Garner, GNJ Tytgat (eds). Dordrecht, The Netherlands, Kluwer Academic Publishers, 1990, pp 183–194

    Google Scholar 

  41. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, McCullough A, Ippoliti AF, Richter JE, et al: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: The US multicenter study. Gastroenterology 102:208–212, 1992

    Google Scholar 

  42. Hetzel DJ: Controlled clinical trials of omeprazole in the long-term management of reflux disease. Digestion 51:49–58, 1992

    PubMed  Google Scholar 

  43. Klinkenberg-Knol EC, Meuwissen SGM: Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy. Digestion 51:44–48, 1992

    PubMed  Google Scholar 

  44. Chen YM, Gelfand DW, Ott DJ, et al: Natural progression of the lower esophageal mucosal ring. Gastrointest Radiol 12:93–98, 1987

    PubMed  Google Scholar 

  45. Wilkins WE, Ridley MG, Pozniak AL: Benign stricture of the oesophagus: Role of non-steroidal anti-inflammatory drugs. Gut 25:478–480, 1984

    PubMed  Google Scholar 

  46. Weaver GA, Harper RL, Storey JA, Jenkins PL, Merrell NB: Nonsteroidal antiinflammatory drugs are associated with gastric outlet obstruction. J Clin Gastroenterol 20:196–198, 1995

    PubMed  Google Scholar 

  47. van Gossum A, Zalcman M, Adler M, Peny MO, Houben JJ, Cremer M: Anorectal stenosis in patients with prolonged use of suppositories containing paracetamol and acetylsalicylic acid. Dig Dis Sci 38:1970–1977, 1993

    PubMed  Google Scholar 

  48. Lanas A, Haggerty P, Hirschowitz BI:In vitro studies of antiinflammatory agents and prostaglandin E2 effects on stimulated normal human fibroblast cultures. Inflammopharmacology 2:377–387, 1994

    Google Scholar 

  49. Durant S, Duval D, Homo-Delarche F: Effect of exogenous prostaglandins and nonsteroidal anti-inflammatory agents on prostaglandin secretion and proliferation of mouse embryo fibroblasts in culture. Prostaglandin Leukot Essent Fatty Acids 38:1–8, 1989

    Google Scholar 

  50. Zamost BJ, Hirschberg J, Ippoliti AF, et al: Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 92:421–428, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hirschowitz, B.I. Gastric secretion of acid and pepsin in patients with esophageal stricture and appropriate controls. Digest Dis Sci 41, 2115–2122 (1996). https://doi.org/10.1007/BF02071389

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02071389

Key words

Navigation